Humacyte (HUMA) Research & Development (2020 - 2026)
Humacyte's Research & Development was $18.14 million in Q2 2026, down 17.5% from $22.01 million a year earlier and down 6.8% from the prior quarter.
Powered by 
Analysis
Humacyte (HUMA) Research & Development (2020 - 2026) Analysis & Trends
On a trailing twelve-month basis, Humacyte's Research & Development was $69.48 million through Jun 30, 2026, down 14.2% year-over-year; for FY2025, it was $69.3 million, down 21.8% from FY2024.
- Research & Development shows a five-year compound annual growth rate of 5.1% (FY2020 to FY2025).
- In earlier years, Research & Development was $88.6 million in FY2024 (+15.7%), $76.55 million in FY2023 (+21.0%), $63.26 million in FY2022 (+3.1%) and $61.34 million in FY2021 (+13.4%).
- Quarterly Research & Development has moved between $14.61 million (Q4 2025) and $23.75 million (Q2 2024) over five years.
- Compared with a year earlier, Research & Development was higher in three of the last eight quarters, with an average decline of 6.8%.
- The best year-over-year quarter for Research & Development over five years was Q2 2023 (growth of 40.2%); the worst was Q4 2025 (a decline of 29.3%).
- Per Business Quant data, HUMA's Research & Development in the three quarters before Q2 2026 was $19.46 million (Q1 2026), $14.61 million (Q4 2025) and $17.27 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | R&D (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 645.01 Bn | 563.54 Bn | 17.26 Bn | 3.65 Bn |
| 2 | AbbVie | 465.23 Bn | 438.39 Bn | 12.70 Bn | 2.34 Bn |
| 3 | Merck | 368.40 Bn | 322.83 Bn | 12.21 Bn | 9.74 Bn |
| 4 | Novartis Ag | 278.02 Bn | 233.89 Bn | 11.24 Bn | -2.85 Bn |
| 5 | Astrazeneca | 254.57 Bn | 228.13 Bn | 12.86 Bn | -4.05 Bn |
| 6 | Amgen | 229.02 Bn | 184.42 Bn | 7.24 Bn | 1.87 Bn |
| 7 | Gilead Sciences | 187.74 Bn | 161.85 Bn | 6.22 Bn | 1.76 Bn |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | 2.81 Bn |
| 9 | Vertex Pharmaceuticals | 133.45 Bn | 105.45 Bn | 2.84 Bn | 993.80 Mn |
| 10 | Humacyte | 147.23 Mn | 147.23 Mn | -825,000.00 | 18.14 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 18.14 Mn |
| Mar 31, 2026 | 19.46 Mn |
| Dec 31, 2025 | 14.61 Mn |
| Sep 30, 2025 | 17.27 Mn |
| Jun 30, 2025 | 22.01 Mn |
| Mar 31, 2025 | 15.42 Mn |
| Dec 31, 2024 | 20.66 Mn |
| Sep 30, 2024 | 22.93 Mn |
| Jun 30, 2024 | 23.75 Mn |
| Mar 31, 2024 | 21.26 Mn |
| Dec 31, 2023 | 20.18 Mn |
| Sep 30, 2023 | 18.55 Mn |
| Jun 30, 2023 | 20.54 Mn |
| Mar 31, 2023 | 17.28 Mn |
| Dec 31, 2022 | 14.96 Mn |
| Sep 30, 2022 | 17.34 Mn |
| Jun 30, 2022 | 14.65 Mn |
| Mar 31, 2022 | 16.31 Mn |
| Dec 31, 2021 | 16.25 Mn |
| Sep 30, 2021 | 15.39 Mn |
API Access
Humacyte Research & Development API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=research-and-development&ticker=HUMA&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "research-and-development", "ticker": "HUMA", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=research-and-development&ticker=HUMA&period=max&api_key=YOUR_API_KEY");
const data = await res.json();